Kidneys work quietly in the background, filtering waste, balancing fluids, and maintaining chemical stability without demanding attention. But this is until som ...
Many people assume that if a supplement is labelled “natural,” it must be safe. But that belief can be misleading. Several ...
Kidney problems never or rarely announce themselves loudly. There is no sudden pain or obvious warning in the early stages, which often makes it difficult to re ...
Kidney aging rarely draws attention until something goes wrong. Over time, these organs quietly lose strength, filter less ...
People with lower kidney function may have higher levels of several blood markers often used in research on Alzheimer's ...
Supplements that seem safe can actually harm weakened kidneys and livers, so always consult a qualified health professional ...
Investing.com -- Novartis announced Friday that its drug Vanrafia has demonstrated effectiveness in slowing the decline of kidney function in adults with IgA nephropathy (IgAN), a progressive ...
Novartis announced that its investigational drug Vanrafia has successfully demonstrated the ability to slow kidney function decline in adults living with IgA nephropathy (IgAN), a chronic and ...
Researchers compared the efficacy of febuxostat for lowering serum urate levels among patients with gout with vs without chronic kidney disease.
Free Malaysia Today on MSN
High nanoplastics exposure can cause kidney damage
Researchers say high concentrations can compromise cell health and function, causing changes to cell shape, survival and cell regulation.
Lower kidney function is associated with elevated Alzheimer’s blood biomarkers, raising implications for dementia diagnosis ...
GlobalData on MSN
Novartis reports final data of ALIGN trial in IgAN
A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results